Description

6H-Azepino[1,2-A]Benzimidazole,7,8,9,10-Tetrahydro-7-Methyl-(9Ci) is a complex, high-purity heterocyclic organic compound that serves as a critical advanced intermediate in modern chemical synthesis. Its fused benzimidazole-azepine structure makes it a valuable building block for pharmaceutical research and the development of novel active ingredients. This compound is essential for R&D chemists and process development scientists working in medicinal chemistry, particularly for targeting neurological and oncological pathways. We supply this material with a focus on batch-to-batch consistency and reliable global logistics to support your most demanding projects.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders and various cancers.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and library synthesis in early-stage drug discovery.
• Biochemical Tool Compound: Serves as a reference standard or a probe molecule in biochemical assays and pharmacological studies.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct polycyclic frameworks due to its unique azepino-benzimidazole core.
• Agrochemical Research: Potential intermediate in the development of new crop protection agents with novel modes of action.
• Material Science Precursor: Investigated for the synthesis of specialized organic electronic materials or ligands for catalytic systems.

Basic Information

Product Name	6H-Azepino[1,2-A]Benzimidazole,7,8,9,10-Tetrahydro-7-Methyl-(9Ci)
CAS No.	117644-50-5
Molecular Formula	C₁₃H₁₆N₂
Molecular Weight	200.28 g/mol
Synonyms	7-Methyl-6,7,8,9-tetrahydro-5H-azepino[1,2-a]benzimidazole; 6,7,8,9-Tetrahydro-7-methyl-5H-azepino[1,2-a]benzimidazole; 7-Methyl-5,6,7,8,9,10-hexahydroazepino[1,2-a]benzimidazole; Tetrahydro-7-methyl-azepino[1,2-a]benzimidazole; Azepino[1,2-a]benzimidazole, 7,8,9,10-tetrahydro-7-methyl-; SCHEMBL2180621; DTXSID60672969
EINECS	Contact for details

Quality Control

Every batch of 6H-Azepino[1,2-A]Benzimidazole,7,8,9,10-Tetrahydro-7-Methyl-(9Ci) is manufactured and tested under a strict quality management system. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and compliance with customer specifications. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment. We support cGMP standards for advanced pharmaceutical intermediates to ensure supply chain integrity for critical research and development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound should be kept under an inert atmosphere if long-term storage is required to maintain stability. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.